Showing results (311-320 of 470) with videos related to
Sort By:
Pageof 47
International Immunology|June 1, 2002
CD6: expression during development, apoptosis and selection of human and mouse thymocytesNora G Singer, David A Fox, Tariq M Haqqi, et al.Transplantation|August 15, 1997
Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerismK S Sivasai, Y G Alevy, B F Duffy, et al.Chest|August 13, 2011
Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosisMarco Mura, Masaki Anraku, Zhihong Yun, et al.Transplantation|February 12, 2000
Cadaveric versus living donor kidney transplantation: a Medicare payment analysisC R Smith, R S Woodward, D S Cohen, et al.American Journal of Respiratory and Critical Care Medicine|July 2, 2015
Effects of Recipient Age and Diagnosis on Health-related Quality-of-Life Benefit of Lung TransplantationLianne G Singer, Noori A Chowdhury, Marie E Faughnan, et al.The Journal of Thoracic and Cardiovascular Surgery|September 5, 2012
Experience with the first 50 ex vivo lung perfusions in clinical transplantationMarcelo Cypel, Jonathan C Yeung, Tiago Machuca, et al.Clinical Transplantation|January 29, 2011
Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosisE F Nash, C Volling, C A Gutierrez, et al.Arthritis and Rheumatism|January 1, 1996
Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytesC Tsai, L A Diaz, N G Singer, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 15, 2020
Extending cytomegalovirus prophylaxis in high-risk (D+/R-) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective studySabina Herrera, Basha Khan, Lianne G Singer, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 11, 2012
Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipientsM-L Luong, S M Hosseini-Moghaddam, L G Singer, et al.Pageof 47